Inventory - CASI Pharmaceuticals Inc (NASDAQ:CASI) - Alpha Spread
C

CASI Pharmaceuticals Inc
NASDAQ:CASI

Watchlist Manager
CASI Pharmaceuticals Inc
NASDAQ:CASI
Watchlist
Price: 6.54 USD -3.25% Market Closed
Market Cap: 87.6m USD
Have any thoughts about
CASI Pharmaceuticals Inc?
Write Note

CASI Pharmaceuticals Inc
Inventory

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

CASI Pharmaceuticals Inc
Inventory Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Inventory Analysis
Latest Figures & CAGR of Competitors

Company Inventory CAGR 3Y CAGR 5Y CAGR 10Y
C
CASI Pharmaceuticals Inc
NASDAQ:CASI
Inventory
$15.9m
CAGR 3-Years
125%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Inventory
$4.2B
CAGR 3-Years
8%
CAGR 5-Years
17%
CAGR 10-Years
15%
Gilead Sciences Inc
NASDAQ:GILD
Inventory
$2B
CAGR 3-Years
5%
CAGR 5-Years
18%
CAGR 10-Years
0%
Amgen Inc
NASDAQ:AMGN
Inventory
$8B
CAGR 3-Years
25%
CAGR 5-Years
20%
CAGR 10-Years
10%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Inventory
$914.6m
CAGR 3-Years
42%
CAGR 5-Years
45%
CAGR 10-Years
54%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Inventory
$2.9B
CAGR 3-Years
13%
CAGR 5-Years
17%
CAGR 10-Years
39%

See Also

What is CASI Pharmaceuticals Inc's Inventory?
Inventory
15.9m USD

Based on the financial report for Dec 31, 2023, CASI Pharmaceuticals Inc's Inventory amounts to 15.9m USD.

What is CASI Pharmaceuticals Inc's Inventory growth rate?
Inventory CAGR 3Y
125%

Over the last year, the Inventory growth was 160%. The average annual Inventory growth rates for CASI Pharmaceuticals Inc have been 125% over the past three years .

Back to Top